Skip to main content
SY

Synakis

Toronto, Canada
Last funding
$1.9M
SeedMay 2026

Synakis has created a vitreous substitute to transform the treatment of retinal detachment which use vitreous substitutes.

About Synakis

How much funding has Synakis raised?

Synakis has raised $1.9M in total funding. The most recent round was Seed. The last funding was announced in May 2026.

Who are Synakis's investors?

Synakis's investors include Ontario Centre of Innovation, UTEST.

Where is Synakis headquartered?

Synakis is headquartered in Toronto, Canada.

What does Synakis do?

Synakis has created a vitreous substitute to transform the treatment of retinal detachment which use vitreous substitutes.

What stage is Synakis at?

Synakis is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Synakis — Funding & Investors." VCBacked, May 11, 2026, https://www.vcbacked.co/company/synakis. Accessed November 20, 2026.
APA
VCBacked. (2026). Synakis — Funding & Investors. Retrieved November 20, 2026, from https://www.vcbacked.co/company/synakis
Wikipedia (cite web)
{{cite web |title=Synakis — Funding & Investors |url=https://www.vcbacked.co/company/synakis |website=VCBacked |access-date=November 20, 2026}}

Profile data sourced and verified per the VCbacked methodology · Last funding round dated

Work at Synakis? Request a listing update

Founder contacts
m***@synakis.ca
linkedin.com/in/●●●●●●
Emails, phones & LinkedIn · 41,000+ verified contacts
Get instant access →